Lv11
50 积分 2026-04-10 加入
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy
19天前
已完结
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial
19天前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
19天前
已完结
Genetic subtype-guided immunochemotherapy in diffuse large B cell lymphoma: The randomized GUIDANCE-01 trial
19天前
已完结
The current value of determining the mismatch repair status of colorectal cancer: A rationale for routine testing
1个月前
已完结
Gastric Cancer: A Review
1个月前
已完结
皖公网安备34019202002308
